LONG-TERM THYROID REPLACEMENT THERAPY AND LEVELS OF LIPOPROTEIN(A) AND OTHER LIPOPROTEINS

被引:55
作者
PAZOS, F
ALVAREZ, JJ
RUBIESPRAT, J
VARELA, C
LASUNCION, MA
机构
[1] HOSP RAMON Y CAJAL, SERV BIOQUIM INVEST, UNIDAD DISLIPEMIAS, E-28034 MADRID, SPAIN
[2] HOSP RAMON Y CAJAL, SERV ENDOCRINOL, E-28034 MADRID, SPAIN
[3] UNIV ALCALA DE HENARES, MADRID, SPAIN
[4] UNIV AUTONOMA BARCELONA, HOSP MAR, DEPT MED, E-08003 BARCELONA, SPAIN
关键词
D O I
10.1210/jc.80.2.562
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is a general interest to know whether lipoprotein(a) [Lp(a)] is under hormonal control. Hypothyroidism is a well known cause of secondary hyperlipidemia, which mainly affects low density lipoprotein (LDL) cholesterol levels, but the result on the effects of L-T-4 replacement therapy on the Lp(a) concentration is controversial. We studied 12 severely hypothyroid, hypercholesterolemic patients under basal conditions and during L-T-4 treatment. We found a rapid decrease in both LDL cholesterol (5.71 +/- 0.62 vs. 4.37 +/- 0.44 mmol/L basally and after 1 month of thyroid replacement, respectively) and apolipoprotein-B (Apo-B) levels (1.89 +/- 0.02 vs. 1.52 +/- 0.17 g/L, respectively); these changes persisted for up 1 yr of analytical euthyroidism and paralleled the improvement in the thyroid status of the patients. In contrast, the plasma Lp(a) concentration did not change at any time (496 +/- 123, 464 +/- 128, and 441 +/- 110 mg/L under basal conditions and after 1 and 14-15 months of thryoid replacement, respectively), and the small fluctuations observed in some patients did not correlate with those in LDL cholesterol or Apo-B, and were not associated with any particular Apo(a) phenotype. In relation to HDL fractions, high density Lipoprotein(3) (HDL(3)) remained stable, but HDL(2) cholesterol and phospholipid levels decreased during treatment, changes that were the inverse of those in postheparin plasma hepatic Lipase activity. Patients in the present study were normotriglyceridemic, except one who was hypertriglyceridemic at diagnosis, but even in this patient, triglyceride levels were unaffected by T-4 substitution therapy, as was postheparin plasma lipoprotein lipase activity. The changes observed in LDL, HDL(2), and hepatic lipase activity delineate the lipoprotein-related response to T-4 replacement therapy, whereas potential individual fluctuations in Lp(a) levels are probably more dependent on other factors, such as the production rate, which are not affected by thyroid hormones.
引用
收藏
页码:562 / 566
页数:5
相关论文
共 47 条
  • [1] ABRAMS JJ, 1981, J LIPID RES, V22, P323
  • [2] PLASMA HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN THYROID-DISEASE
    AGDEPPA, D
    MACARON, C
    MALLIK, T
    SCHNUDA, ND
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1979, 49 (05) : 726 - 729
  • [3] INTERINDIVIDUAL VARIATION IN THE PARTITION OF LIPOPROTEIN(A) INTO LIPOPROTEIN SUBFRACTIONS
    ALVAREZ, JJ
    LASUNCION, MA
    OLMOS, JM
    HERRERA, E
    [J]. CLINICAL BIOCHEMISTRY, 1993, 26 (05) : 399 - 408
  • [4] THE ASSOCIATION BETWEEN SERUM LP(A) CONCENTRATIONS AND ANGIOGRAPHICALLY ASSESSED CORONARY ATHEROSCLEROSIS - DEPENDENCE ON SERUM LDL LEVELS
    ARMSTRONG, VW
    CREMER, P
    EBERLE, E
    MANKE, A
    SCHULZE, F
    WIELAND, H
    KREUZER, H
    SEIDEL, D
    [J]. ATHEROSCLEROSIS, 1986, 62 (03) : 249 - 257
  • [5] AUGUET T, 1993, NEPHROL DIAL TRANSPL, V8, P1099
  • [6] A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS
    BROWN, MS
    GOLDSTEIN, JL
    [J]. SCIENCE, 1986, 232 (4746) : 34 - 47
  • [7] REGULATORY ROLE OF TRIIODOTHYRONINE IN THE DEGRADATION OF LOW-DENSITY LIPOPROTEIN BY CULTURED HUMAN-SKIN FIBROBLASTS
    CHAIT, A
    BIERMAN, EL
    ALBERS, JJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1979, 48 (05) : 887 - 889
  • [8] COREY JE, 1977, J LAB CLIN MED, V89, P666
  • [9] APOLIPOPROTEIN-B MESSENGER-RNA EDITING IS MODULATED BY THYROID-HORMONE ANALOGS BUT NOT GROWTH-HORMONE ADMINISTRATION IN THE RAT
    DAVIDSON, NO
    CARLOS, RC
    LUKASZEWICZ, AM
    [J]. MOLECULAR ENDOCRINOLOGY, 1990, 4 (05) : 779 - 785
  • [10] DAVIDSON NO, 1988, J BIOL CHEM, V263, P13482